| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:30 | Modular Medical launches digital tools for insulin pump training | 1 | Investing.com | ||
| 15:02 | Modular Medical, Inc.: Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery System | 162 | ACCESS Newswire | Game-Based Education Tools Designed to Help Improve Patient Familiarity with Pump Therapy and Support Healthcare Providers in Identifying Candidates for Pump Adoption SAN DIEGO, CA / ACCESS Newswire... ► Artikel lesen | |
| 07.10. | Modular Medical, Inc.: Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th | 263 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / October 7, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 29.09. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 08.09. | Modular Medical, Inc.: Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026 | 332 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 04.09. | Modular Medical Aktie steigt nach Vertrag mit führendem Pharmacy Benefit Manager | 2 | Investing.com Deutsch | ||
| 04.09. | Modular Medical sichert sich Vertrag mit landesweitem US-Apothekenmanager | 1 | Investing.com Deutsch | ||
| 04.09. | Modular Medical secures contract with national U.S. pharmacy manager | 2 | Investing.com | ||
| 04.09. | Modular Medical, Inc.: Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump | 438 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial... ► Artikel lesen | |
| 03.09. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.09. | Modular Medical, Inc.: Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements | 358 | ACCESS Newswire | Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot Customization SAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / Modular Medical, Inc. ("Modular Medical" or "the... ► Artikel lesen | |
| 03.09. | EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades | 2 | Benzinga.com | ||
| 02.09. | Modular Medical, Inc.: Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled 'The Road To Revenue: Modular Medical's Strategy For Launching Pivot' Featuring Modular Medical CEO - Friday, September 4, 2026 | 451 | ACCESS Newswire | Meet with Modular Medical CEO Jeb Besser.Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal... ► Artikel lesen | |
| 02.09. | 6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More | 896 | AFX News | BEIJING (dpa-AFX) - Today's after-hours gainers in the healthcare sector included Universe Pharmaceuticals, which drew attention after disclosing multiple Schedule 13G filings; bioAffinity Technologies... ► Artikel lesen | |
| 14.08. | Modular Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.08. | Modular Medical, Inc.: Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference | 417 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 04.08. | Modular Medical to initiate first phase of Pivot pump launch in October | 1 | MassDevice | ||
| 03.08. | Modular Medical, Inc.: Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026 | 497 | ACCESS Newswire | First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption... ► Artikel lesen | |
| 23.07. | Modular Medical forms advisory council for Pivot insulin pump | 3 | Investing.com | ||
| 23.07. | Modular Medical, Inc.: Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman | 348 | ACCESS Newswire | - Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,322 | +2,07 % | Teladoc Health, Inc.: Teladoc Health to Announce Third Quarter 2026 Financial Results | ||
| SERNOVA BIOTHERAPEUTICS | 0,068 | 0,00 % | Sernova Biotherapeutics Inc mit EILMELDUNG: Kaufen Insider bereits massiv? - Handeln Sie, bevor es zu spät ist! | ||
| CERENOME | 1,398 | -15,48 % | Cerenome, Inc.: Cerenome Secures In-Network Agreement with Florida Blue for CNSide CSF Tumor Cell Enumeration and Molecular Profile Tests | ||
| ATOSSA THERAPEUTICS | 2,220 | -11,20 % | Atossa Therapeutics schließt CVR-Vereinbarung für Erlöse aus FDA-Prüfgutschein | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 14,400 | 0,00 % | Tandem Diabetes Care Q2 2026 Earnings Call Transcript | ||
| CO-DIAGNOSTICS | 0,727 | -4,93 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 12,715 | +2,38 % | QuidelOrtho Reports Q2 2026 Results: Full Earnings Call Transcript | ||
| VERU | 2,210 | +3,76 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 6,220 | +1,80 % | 6,4 Millionen US-Dollar pro Patient: Warum Medtronic, Lifeward und NurExone an drei Stufen der Rückenmarksversorgung ansetzen | ||
| CLOVER HEALTH INVESTMENTS | 4,190 | -2,33 % | Why Is Clover Health (CLOV) Stock Soaring Today | ||
| SENSEONICS | 7,600 | +4,83 % | Senseonics Holdings Q2 2026 Earnings Call: Complete Transcript | ||
| TEMPEST THERAPEUTICS | 0,636 | -0,53 % | Tempest Therapeutics: Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise | ||
| NANO-X IMAGING | 0,491 | -3,84 % | NANO-X IMAGING LTD: Nanox Selected as One of TIME's Best Inventions of 2026 for its Nanox.ARC X | ||
| IMUNON | 0,930 | 0,00 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen |